BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38095085)

  • 1. The Role of
    Chiang DY; Verkerk AO; Victorio R; Shneyer BI; van der Vaart B; Jouni M; Narendran N; Kc A; Sampognaro JR; Vetrano-Olsen F; Oh JS; Buys E; de Jonge B; Shah DA; Kiviniemi T; Burridge PW; Bezzina CR; Akhmanova A; MacRae CA
    Circ Res; 2024 Jan; 134(1):46-59. PubMed ID: 38095085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreasing microtubule detyrosination modulates Nav1.5 subcellular distribution and restores sodium current in mdx cardiomyocytes.
    Nasilli G; de Waal TM; Marchal GA; Bertoli G; Veldkamp MW; Rothenberg E; Casini S; Remme CA
    Cardiovasc Res; 2024 May; 120(7):723-734. PubMed ID: 38395031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome.
    Liang P; Sallam K; Wu H; Li Y; Itzhaki I; Garg P; Zhang Y; Vermglinchan V; Lan F; Gu M; Gong T; Zhuge Y; He C; Ebert AD; Sanchez-Freire V; Churko J; Hu S; Sharma A; Lam CK; Scheinman MM; Bers DM; Wu JC
    J Am Coll Cardiol; 2016 Nov; 68(19):2086-2096. PubMed ID: 27810048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-arrhythmic potential of the late sodium current inhibitor GS-458967 in murine Scn5a-1798insD+/- and human SCN5A-1795insD+/- iPSC-derived cardiomyocytes.
    Portero V; Casini S; Hoekstra M; Verkerk AO; Mengarelli I; Belardinelli L; Rajamani S; Wilde AAM; Bezzina CR; Veldkamp MW; Remme CA
    Cardiovasc Res; 2017 Jun; 113(7):829-838. PubMed ID: 28430892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis.
    Te Riele AS; Agullo-Pascual E; James CA; Leo-Macias A; Cerrone M; Zhang M; Lin X; Lin B; Sobreira NL; Amat-Alarcon N; Marsman RF; Murray B; Tichnell C; van der Heijden JF; Dooijes D; van Veen TA; Tandri H; Fowler SJ; Hauer RN; Tomaselli G; van den Berg MP; Taylor MR; Brun F; Sinagra G; Wilde AA; Mestroni L; Bezzina CR; Calkins H; Peter van Tintelen J; Bu L; Delmar M; Judge DP
    Cardiovasc Res; 2017 Jan; 113(1):102-111. PubMed ID: 28069705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Readthrough-Promoting Drugs Gentamicin and PTC124 Fail to Rescue Nav1.5 Function of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Carrying Nonsense Mutations in the Sodium Channel Gene SCN5A.
    Kosmidis G; Veerman CC; Casini S; Verkerk AO; van de Pas S; Bellin M; Wilde AA; Mummery CL; Bezzina CR
    Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27784737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cellular model of Brugada syndrome with SCN10A variants using human-induced pluripotent stem cell-derived cardiomyocytes.
    El-Battrawy I; Albers S; Cyganek L; Zhao Z; Lan H; Li X; Xu Q; Kleinsorge M; Huang M; Liao Z; Zhong R; Rudic B; Müller J; Dinkel H; Lang S; Diecke S; Zimmermann WH; Utikal J; Wieland T; Borggrefe M; Zhou X; Akin I
    Europace; 2019 Sep; 21(9):1410-1421. PubMed ID: 31106349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. hiPSC-derived cardiomyocytes from Brugada Syndrome patients without identified mutations do not exhibit clear cellular electrophysiological abnormalities.
    Veerman CC; Mengarelli I; Guan K; Stauske M; Barc J; Tan HL; Wilde AA; Verkerk AO; Bezzina CR
    Sci Rep; 2016 Aug; 6():30967. PubMed ID: 27485484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing human iPSC-cardiomyocytes versus HEK293T cells unveils disease-causing effects of Brugada mutation A735V of Na
    de la Roche J; Angsutararux P; Kempf H; Janan M; Bolesani E; Thiemann S; Wojciechowski D; Coffee M; Franke A; Schwanke K; Leffler A; Luanpitpong S; Issaragrisil S; Fischer M; Zweigerdt R
    Sci Rep; 2019 Aug; 9(1):11173. PubMed ID: 31371804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prokaryotic voltage-gated sodium channels are more effective than endogenous Na
    Needs D; Wu T; Nguyen HX; Henriquez CS; Bursac N
    Am J Physiol Heart Circ Physiol; 2023 Nov; 325(5):H1178-H1192. PubMed ID: 37737736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
    Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
    PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal interventricular differences in tissue architecture underlie right ventricular susceptibility to conduction abnormalities in a mouse model of Brugada syndrome.
    Kelly A; Salerno S; Connolly A; Bishop M; Charpentier F; Stølen T; Smith GL
    Cardiovasc Res; 2018 Apr; 114(5):724-736. PubMed ID: 29267949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional Dysregulation Underlies Both Monogenic Arrhythmia Syndrome and Common Modifiers of Cardiac Repolarization.
    Bersell KR; Yang T; Mosley JD; Glazer AM; Hale AT; Kryshtal DO; Kim K; Steimle JD; Brown JD; Salem JE; Campbell CC; Hong CC; Wells QS; Johnson AN; Short L; Blair MA; Behr ER; Petropoulou E; Jamshidi Y; Benson MD; Keyes MJ; Ngo D; Vasan RS; Yang Q; Gerszten RE; Shaffer C; Parikh S; Sheng Q; Kannankeril PJ; Moskowitz IP; York JD; Wang TJ; Knollmann BC; Roden DM
    Circulation; 2023 Mar; 147(10):824-840. PubMed ID: 36524479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tbx5 variants disrupt Nav1.5 function differently in patients diagnosed with Brugada or Long QT Syndrome.
    Nieto-Marín P; Tinaquero D; Utrilla RG; Cebrián J; González-Guerra A; Crespo-García T; Cámara-Checa A; Rubio-Alarcón M; Dago M; Alfayate S; Filgueiras-Rama D; Peinado R; López-Sendón JL; Jalife J; Tamargo J; Bernal JA; Caballero R; Delpón E;
    Cardiovasc Res; 2022 Mar; 118(4):1046-1060. PubMed ID: 33576403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Na
    Pierre M; Djemai M; Poulin H; Chahine M
    Sci Rep; 2021 Aug; 11(1):17168. PubMed ID: 34433864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical Roles of Xirp Proteins in Cardiac Conduction and Their Rare Variants Identified in Sudden Unexplained Nocturnal Death Syndrome and Brugada Syndrome in Chinese Han Population.
    Huang L; Wu KH; Zhang L; Wang Q; Tang S; Wu Q; Jiang PH; Lin JJ; Guo J; Wang L; Loh SH; Cheng J
    J Am Heart Assoc; 2018 Jan; 7(1):. PubMed ID: 29306897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biophysical comparison of sodium currents in native cardiac myocytes and human induced pluripotent stem cell-derived cardiomyocytes.
    Goodrow RJ; Desai S; Treat JA; Panama BK; Desai M; Nesterenko VV; Cordeiro JM
    J Pharmacol Toxicol Methods; 2018; 90():19-30. PubMed ID: 29128504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium channel current loss of function in induced pluripotent stem cell-derived cardiomyocytes from a Brugada syndrome patient.
    Selga E; Sendfeld F; Martinez-Moreno R; Medine CN; Tura-Ceide O; Wilmut SI; Pérez GJ; Scornik FS; Brugada R; Mills NL
    J Mol Cell Cardiol; 2018 Jan; 114():10-19. PubMed ID: 29024690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brugada syndrome trafficking-defective Nav1.5 channels can trap cardiac Kir2.1/2.2 channels.
    Pérez-Hernández M; Matamoros M; Alfayate S; Nieto-Marín P; Utrilla RG; Tinaquero D; de Andrés R; Crespo T; Ponce-Balbuena D; Willis BC; Jiménez-Vazquez EN; Guerrero-Serna G; da Rocha AM; Campbell K; Herron TJ; Díez-Guerra FJ; Tamargo J; Jalife J; Caballero R; Delpón E
    JCI Insight; 2018 Sep; 3(18):. PubMed ID: 30232268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility.
    Barc J; Tadros R; Glinge C; Chiang DY; Jouni M; Simonet F; Jurgens SJ; Baudic M; Nicastro M; Potet F; Offerhaus JA; Walsh R; Choi SH; Verkerk AO; Mizusawa Y; Anys S; Minois D; Arnaud M; Duchateau J; Wijeyeratne YD; Muir A; Papadakis M; Castelletti S; Torchio M; Ortuño CG; Lacunza J; Giachino DF; Cerrato N; Martins RP; Campuzano O; Van Dooren S; Thollet A; Kyndt F; Mazzanti A; Clémenty N; Bisson A; Corveleyn A; Stallmeyer B; Dittmann S; Saenen J; Noël A; Honarbakhsh S; Rudic B; Marzak H; Rowe MK; Federspiel C; Le Page S; Placide L; Milhem A; Barajas-Martinez H; Beckmann BM; Krapels IP; Steinfurt J; Winkel BG; Jabbari R; Shoemaker MB; Boukens BJ; Škorić-Milosavljević D; Bikker H; Manevy F; Lichtner P; Ribasés M; Meitinger T; Müller-Nurasyid M; ; Veldink JH; van den Berg LH; Van Damme P; Cusi D; Lanzani C; Rigade S; Charpentier E; Baron E; Bonnaud S; Lecointe S; Donnart A; Le Marec H; Chatel S; Karakachoff M; Bézieau S; London B; Tfelt-Hansen J; Roden D; Odening KE; Cerrone M; Chinitz LA; Volders PG; van de Berg MP; Laurent G; Faivre L; Antzelevitch C; Kääb S; Arnaout AA; Dupuis JM; Pasquie JL; Billon O; Roberts JD; Jesel L; Borggrefe M; Lambiase PD; Mansourati J; Loeys B; Leenhardt A; Guicheney P; Maury P; Schulze-Bahr E; Robyns T; Breckpot J; Babuty D; Priori SG; Napolitano C; ; de Asmundis C; Brugada P; Brugada R; Arbelo E; Brugada J; Mabo P; Behar N; Giustetto C; Molina MS; Gimeno JR; Hasdemir C; Schwartz PJ; Crotti L; McKeown PP; Sharma S; Behr ER; Haissaguerre M; Sacher F; Rooryck C; Tan HL; Remme CA; Postema PG; Delmar M; Ellinor PT; Lubitz SA; Gourraud JB; Tanck MW; George AL; MacRae CA; Burridge PW; Dina C; Probst V; Wilde AA; Schott JJ; Redon R; Bezzina CR
    Nat Genet; 2022 Mar; 54(3):232-239. PubMed ID: 35210625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.